Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54991960)
Watch
English
USPC-ARK-19
cell line
USPC-ARK19
ARK19
In more languages
edit
Statements
instance of
cell line
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
cancer cell line
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
described by source
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2).
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
established from medical condition
uterine corpus serous adenocarcinoma
1 reference
stated in
Cellosaurus release 26
retrieved
14 June 2018
Cellosaurus ID
CVCL_IV90
derived from organism type
Homo sapiens
sex or gender
female
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
Identifiers
Cellosaurus ID
CVCL_IV90
1 reference
stated in
Cellosaurus release 44
retrieved
31 January 2023
Cellosaurus ID
CVCL_IV90
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit